ITMCTR2100005160招募中4 期
The research of Sanghuangporusbaumii tablets on immune regulation of colorectal cancer patients after chemotherapy
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 75（—）
- 性别
- All
入选标准
- •1. Colorectal cancer patients (TNM stage III-IV);
- •2. Those who are suitable for chemotherapy (the chemotherapy regimen is not limited), and patients with impaired immunity after chemotherapy (the ratio of CD4/CD8 in peripheral blood <1.4);
- •3. Age 18~75 years old, gender is not limited;
- •4. ECOG score 0~1 points;
- •5. Expected survival > 6 months.
排除标准
- •1. Those with primary immunodeficiency disease and other serious infectious diseases,
- •2. Patients who have received immunomodulatory therapy before;
- •3. Patients with abnormal blood routine, liver function and renal function;
- •4. Pregnant or lactating women, and persons with mental disorders;
- •5. Those with poor compliance are easily lost to the follow-up.
研究者
相似试验
尚未招募
2 期
Clinical study of Rongqingbaohuashuan powder on patients with carotid atherosclerosisHyperlipidemiaITMCTR2100005121Qilu Hospital of Shandong University
尚未招募
2 期
A Pharmacotherapeutic study of Gorakhmundi( Sphaeranthus indicus Linn) Kadha and Patha(Cissampelos pareira Linn) Moola Taila Nasyam in the management of MigraineCTRI/2021/08/035661Govt Dhanwanthari Ayurvedic college and hospital Ujjain
招募中
不适用
Clinical Study of Sanqihuogutang Modified combine with Extracorporeal Shock Wave on Patients with early Avascular Necrosis of Femoral Head with Qi-Blood Stagnation typeOsteonecrosis of Femur HeadITMCTR2200005784The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
尚未招募
3 期
somraji tail ka twak kandu par prabhavCTRI/2023/04/051965Goverment Ayurvedic college,Patna
尚未招募
1 期
A Randomized Double-blind Controlled Study of Sequential Treatment of Traditional Chinese Medicine for Bronchodilatation Secondary to MDR-PA ColonizatioBronchiectasisITMCTR2000003365onghua Hospital Shanghai University of Traditional Chinese Medicine